Adherence to Adjuvant Endocrine Therapy in Insured Black and White Breast Cancer Survivors: Exploring Adherence Measures in Patient Data

BACKGROUND: Adjuvant endocrine therapy (AET) is a critical therapy in that it improves survival in women with hormone receptor-positive (HR+) breast cancer (BC), but adherence to AET is suboptimal. The purpose of this study was to fill scientific gaps about predictors of adherence to AET among black...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Manag Care Spec Pharm
Auteurs principaux: Sheppard, Vanessa B., He, Jun, Sutton, Arnethea, Cromwell, Lee, Adunlin, Georges, Salgado, Teresa M., Tolsma, Dennis, Trout, Martha, Robinson, Brandi E., Edmonds, Megan C., Bosworth, Hayden B., Tadesse, Mahlet G.
Format: Artigo
Langue:Inglês
Publié: Academy of Managed Care Pharmacy 2019
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6758918/
https://ncbi.nlm.nih.gov/pubmed/31039059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18553/jmcp.2019.25.5.578
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires